We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$5.27B
AUM Growth
+$317M
Cap. Flow
-$90.4M
Cap. Flow %
-1.72%
Top 10 Hldgs %
18.18%
Holding
150
New
11
Increased
79
Reduced
42
Closed
18

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$45.2M
2
CST
CST Brands, Inc.
CST
+$28.8M
3
ZTS icon
Zoetis
ZTS
+$26.9M
4
ADT
ADT Corp
ADT
+$26.6M
5
BJRI icon
BJ's Restaurants
BJRI
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.62%
2 Industrials 16.17%
3 Financials 14.3%
4 Consumer Discretionary 10.25%
5 Technology 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAC icon
1
Enerpac Tool Group
EPAC
$1.85B
$133M 2.52%
3,421,475
+52,185
+2% +$1.9M
AWH
2
DELISTED
Allied World Assurance Co Hld Lt
AWH
$106M 2.02%
3,203,745
-642,930
-17% -$20.2M
CST
3
DELISTED
CST Brands, Inc.
CST
$94.7M 1.8%
3,176,285
+920,750
+41% +$28.8M
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.79B
$92.2M 1.75%
784,130
+42,835
+6% +$5.05M
SXT icon
5
Sensient Technologies
SXT
$5.31B
$91.9M 1.74%
1,918,920
-4,705
-0.2% -$206K
UMBF icon
6
UMB Financial
UMBF
$11.3B
$90.8M 1.72%
1,671,150
-61,615
-4% -$3.59M
ATR icon
7
AptarGroup
ATR
$8.7B
$89.2M 1.69%
1,482,745
+132,945
+10% +$7.87M
TRS icon
8
TriMas Corp
TRS
$1.42B
$88.8M 1.69%
2,988,601
+263,682
+10% +$7.85M
ENH
9
DELISTED
Endurance Specialty Holdings Ltd
ENH
$85.8M 1.63%
1,596,985
+178,565
+13% +$9.27M
CPHD
10
DELISTED
Cepheid Inc
CPHD
$84.9M 1.61%
2,175,365
+510,260
+31% +$18.5M
HTSI
11
DELISTED
HARRIS TEETER SUPERMARKETS INC COM STK (NC)
HTSI
$80.5M 1.53%
1,636,820
-41,130
-2% -$2.02M
THS
12
DELISTED
Treehouse Foods
THS
$80.2M 1.52%
1,199,520
+3,595
+0.3% +$248K
CLC
13
DELISTED
Clarcor
CLC
$79.3M 1.5%
1,427,150
+39,110
+3% +$2.16M
CASY icon
14
Casey's General Stores
CASY
$32.3B
$79.1M 1.5%
1,078,205
-3,530
-0.3% -$240K
IEX icon
15
IDEX
IEX
$17.1B
$78.6M 1.49%
1,204,660
+27,590
+2% +$1.67M
NATI
16
DELISTED
National Instruments Corp
NATI
$77.7M 1.48%
2,511,894
+47,870
+2% +$1.39M
WLY icon
17
John Wiley & Sons Class A
WLY
$2.86B
$76.1M 1.44%
1,595,035
-25,985
-2% -$1.16M
TFX icon
18
Teleflex
TFX
$5.93B
$72.8M 1.38%
884,820
+234,830
+36% +$18.5M
WEX icon
19
WEX
WEX
$6.47B
$72.5M 1.38%
826,440
+8,955
+1% +$757K
CATM
20
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$71.6M 1.36%
1,930,650
-232,195
-11% -$7.82M
ESL
21
DELISTED
Esterline Technologies
ESL
$71.6M 1.36%
895,755
+22,700
+3% +$1.82M
PB icon
22
Prosperity Bancshares
PB
$8.91B
$71.3M 1.35%
1,153,705
+29,405
+3% +$1.75M
RP
23
DELISTED
RealPage, Inc.
RP
$63.5M 1.21%
2,749,760
+42,235
+2% +$885K
RAVN
24
DELISTED
Raven Industries Inc
RAVN
$62.7M 1.19%
1,915,660
-7,365
-0.4% -$231K
WST icon
25
West Pharmaceutical
WST
$23.8B
$61.4M 1.17%
1,493,150
-728,780
-33% -$27.8M

Similar funds

Champlain Investment Partners's Q3 2013 Portfolio in Review

As of Q3 2013, Champlain Investment Partners held 150 positions worth $5.27B, up 6.4% from $4.95B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q3 2013 filing shows 11 new, 79 increased, 42 reduced and 18 closed positions. Its largest new stake was Haemonetics: 1,078,265 shares worth $43M. The largest sale was LUFKIN IND INC, an estimated $94M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

  • Champlain Investment Partners's largest Q3 2013 buy was Haemonetics: 1,078,265 shares worth $43M.
  • Champlain Investment Partners added most to CST Brands, Inc. in Q3 2013, an estimated $28.8M increase.
  • Champlain Investment Partners's biggest Q3 2013 reduction was Protolabs, cutting an estimated $36.4M.
  • Champlain Investment Partners fully exited LUFKIN IND INC in Q3 2013, selling an estimated $94M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $5.27B portfolio in Q3 2013.
  • Champlain Investment Partners opened 11 new positions and closed 18 in Q3 2013.
  • Champlain Investment Partners's portfolio value rose 6.4% quarter-over-quarter to $5.27B.

Based on Champlain Investment Partners's 13F filing for Q3 2013, filed 12 Nov 2013.